Freeze dried plasma commercial viability activities
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH20C0088
- Awardee
-
Vascular Solutions LLC UEI CMZHMVNAALR1
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $9,744,757
Award facts
- Opportunity
-
- W81XWH20R0027 Solicitation number
- Contract value 100% obligated
- $9,744,757.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Maple Grove, MN 55369, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $533,585 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $1,399,559 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $4,499,870 | |
| Exercise an Option | $1,000,000 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,094,071 | |
| Supplemental Agreement for work within scope | -$469 | |
| Exercise an Option | $614,612 | |
| Funding Only Action | -$1,000,000 | |
| Original award | $1,603,529 |
Show all 14
About this award
The Defense Health Agency awarded a $9.7 million firm fixed price contract to Vascular Solutions LLC (a Teleflex Medical division) on September 9, 2020, for freeze dried plasma commercial viability activities. The contract, which extends through December 31, 2025, supports the development and commercialization of freeze dried plasma products and related activities. The work is being performed in Maple Grove, Minnesota, and no set-aside designation was used for this award.
This contract reflects the Department of Defense's investment in advancing blood product alternatives and military medical readiness capabilities. Freeze dried plasma represents a critical capability for military medical operations, offering extended shelf life and improved logistical advantages compared to liquid plasma products. The extended performance period through 2025 indicates a phased approach to achieving commercial viability milestones, allowing the contractor to progress through development, testing, and commercialization stages while working with the Defense Health Agency to support both military and potentially broader healthcare applications.
Quick answers
Who was awarded contract W81XWH20C0088?
W81XWH20C0088 was awarded to Vascular Solutions LLC by Defense Health Agency (Department of Defense) on September 9, 2020.
How much is contract W81XWH20C0088 worth?
The government has obligated $9,744,757 on W81XWH20C0088.
Was contract W81XWH20C0088 competed?
The extent of competition for W81XWH20C0088 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award